Toboroz
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
NCT07805707· 3. fázis· GlaxoSmithKline· Forrás
Contact: Jason Agran (principal investigator)
Toboroz
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395· 2. fázis· GlaxoSmithKline· Forrás
Contact: Vasundhara Cheekati (principal investigator)
Toboroz
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT07202546· 2. fázis· ViiV Healthcare· Forrás
Contact: Caitlin Moran (principal investigator)
Toboroz
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214· 3. fázis· GlaxoSmithKline· Forrás
Contact: Ngozika Orjioke (principal investigator)
Toboroz
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101· 3. fázis· GlaxoSmithKline· Forrás
Contact: Vikas Gupta (principal investigator)
Fut, nem toboroz
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
NCT06694805· 3. fázis· ViiV Healthcare· Forrás
Toboroz
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698· 2. fázis· GlaxoSmithKline· Forrás
Contact: Lance Stein (principal investigator)
Fut, nem toboroz
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
NCT06411249· 4. fázis· GlaxoSmithKline· Forrás
Toboroz
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588· 3. fázis· GlaxoSmithKline· Forrás
Contact: Dong Shin (principal investigator)
Toboroz
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
NCT05674656· 1/2. fázis· ViiV Healthcare· Forrás
Contact: Andres Camacho-Gonzalez (principal investigator)
Fut, nem toboroz
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
NCT07217184· 1/2. fázis· GlaxoSmithKline· Forrás
Toboroz
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
NCT04641247· 2. fázis· GlaxoSmithKline· Forrás
Contact: Meaghan Tenney (principal investigator)
Fut, nem toboroz
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
NCT07217119· 1/2. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT04126200· 1/2. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
NCT03981796· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113· 2. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
NCT02938520· 3. fázis· ViiV Healthcare· Forrás
Fut, nem toboroz
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
NCT02655016· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
NCT02817633· 1. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
NCT02362503· 3. fázis· ViiV Healthcare· Forrás